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Dengue fever is a reportable disease in Germany.
Surveillance data from 2001 and 2002 were analyzed and
compared to travel patterns. Imported dengue fever
increased strongly in this time. Most infections were
acquired in Southeast Asia, specifically Thailand. The 2002
epidemic in Brazil was also reflected in these data.
D
engue fever is endemic in many tropical regions
worldwide (1,2). The disease is caused by any of four
serotypes of dengue virus, a flavivirus. The World Health
Organization estimates that 50 million infections and
22,000 dengue-related deaths occur annually. In many
countries, the incidence of dengue fever in 2002 increased
compared to previous years. The geographic range of
dengue continues to expand, as a recent large outbreak in
Australia’s Northern Queensland demonstrates (3).
Travel to dengue-endemic areas carries the risk of
acquiring the disease. Each year, an estimated 3 million
German residents spend time in such countries. Country-
specific risk for travel-associated dengue fever needs to be
monitored to focus pretravel advice. In the absence of data
on the true incidence in travelers (including asymptomatic
infections and those not coming to medical attention in
Germany), cases of symptomatic imported dengue fever
diagnosed in Germany indicate temporal and geographic
trends in all travel-associated dengue infections.
An improved surveillance system for mandatory case
reporting of infectious diseases, including dengue, was
implemented in Germany in January 2001. Under the
Infectious Disease Control Act, German laboratories must
notify local public health authorities of test results
fulfilling the case definition for acute dengue virus
infection, i.e., detection of viral antigen or RNA, a fourfold
or greater increase in antibody titers between acute- and
convalescent-phase serum samples, or detection of
immunoglobulin (Ig) M antibodies to a dengue virus. The
inclusion of positive IgM test results, typically the first
laboratory evidence to indicate infection, enhances
timeliness of reporting. In most cases, paired serum
samples are tested. Local authorities then gather additional
information on the patient (clinical signs, demographics,
travel destination). If the case definition is fulfilled
(clinical dengue plus definitive or probable laboratory
evidence), the case is reported through state authorities to
the central database at the Robert Koch Institute. 
The Study
We analyzed surveillance data on temporal trends,
demographics, and country of infection from January 2001
to December 2002. Using recent air travel data, we calcu-
lated relative country-specific dengue fever risks for trav-
elers from Germany. Information on the numbers of air
travelers from Germany to foreign destinations in 2002 is
available from the Federal Statistical Office (Statistisches
Bundesamt, air tourism statistics, 2002), which receives
reports on ticketed destinations from all airlines that board
passengers at German airports. The Thailand Authority of
Tourism provides monthly statistics on the number of vis-
itors arriving from Germany in 2002 (available from
http://www.tat.or.th/stat/download.htm), as does the
Brazilian Tourist Office for 2001 (available from
http://www.brazil.org.uk/page.php?cid=1195). On the
basis of likely month of infection, monthly risk for dengue
per 100,000 travelers from Germany to Thailand and
Brazil was calculated. 
Sixty cases meeting the case definition were reported in
2001, and 231 cases were reported in 2002. Case reports
rose continuously from 7 cases in the first quarter of 2001
to 82 cases in the second quarter of 2002 (Figure 1). In
both years, 55% of cases were male. The median age at
infection was 37.5 years (range 20–62 years) in 2001 and
34 years (range 5–71 years) in 2002. Travelers to Thailand
(n = 114, median age 31.5 years) were significantly
younger than travelers to Brazil (n = 40, median age 40
years) (p < 0.001). Six cases had hemorrhagic signs, but
none fulfilled the World Health Organization case defini-
tion for dengue hemorrhagic fever or dengue shock syn-
drome. No deaths from dengue fever were reported.
Information on travel history was available for all cases
in 2001 and for 98% of 2002 cases. Overall, 39.4% of
infections were acquired in Thailand (2001: 36.1%, 2002:
40.6%). In 2001, stays in Venezuela (8.3%), India (6.6%),
and Cambodia (6.6%)—all countries endemic for dengue
fever—were also frequently implicated. The proportion of
cases imported from Brazil rose from 4.9% in 2001 to
15.5% in 2002 (p = 0.05). In the first half of 2002, 25.6%
of all cases were associated with travel to Brazil. Cases
imported from Thailand peaked in the second and third
quarter of 2002. Venezuela contributed 1.7% of cases in
2002, compared to 8.3% in 2001 (p = 0.02). A case of
nosocomial dengue virus transmitted by needlestick injury
was observed in a German hospital nurse in 2002 (4).
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among German travelers were noted for Thailand
(27.9/100,000 travelers), Brazil (22.8/100,000), South
America except Brazil (21.1/100,000), the Lesser Antilles
(19.1/100,000), the Central American mainland south of
Mexico (16.3/100,000), the former Indochina (15.2/
100,000), and Indonesia (14.8/100,000) (Table).
The incidence of dengue fever among German travelers
to Thailand ranged from 2/100,000 in January and
February to >70/100,000 in April (Figure 2). While travel
peaks during the winter months, dengue incidence was
strongly elevated during the mid-year rainy season and the
month preceding it. Numbers of travelers to Brazil were
slightly higher from January to March compared to the rest
of the year (Figure 3). The incidence of dengue fever
showed a distinct peak in February and March, reaching
39/100,000 travelers in March, and was very low from
May to December.
Conclusions 
Some of the steady increase in case reports in early
2001 likely reflects knowledge and acceptance of the
recently improved surveillance system among physicians
and laboratories who diagnose dengue. The further steep
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Figure 1. Cases of dengue fever reported in
Germany 2001 (n = 60) and 2002 (n = 231) by
region of acquisition. 
Table. Regional risk for dengue fever in German travelers, 2002 
Region  Country or area 
No. of travelers flying 
in from Germany 
Mentions of 
destination(s) among 
dengue patients 
Incidence (cases/ 
100,000 air travelers 
from Germany) 
Southeast Asia  Thailand  347,569  97  27.9 
South America  Brazil  162,264  37  22.8 
South America  Colombia, Venezuela, Suriname, Trinidad 
and Tobago, Aruba, Curaçao, Bonair 
61,739  13  21.1 
Central America  Lesser Antilles Islands
a  20,989  4  19.1 
Central America  Guatemala, Honduras, Belize, El Salvador, 
Nicaragua, Costa Rica, Panama 
24,564  4  16.3 
Southeast Asia  Laos, Vietnam, Cambodia (Indochina)  65,963  10  15.2 
Southeast Asia  Indonesia  88,053  13  14.8 
Africa  Ghana  22,900  3  13.1 
South Asia  India, Sri Lanka  220,169  18  8.2 
South America  Ecuador, Peru, Bolivia  43,928  3  6.8 
Southeast Asia  Philippines  54,231  3  5.5 
Southeast Asia  Malaysia  43,698  2  4.6 
Central America  Greater Antilles Islands
b  429,614  9  2.1 
Asia  Asia, Southeast Asia, Taiwan, Singapore  No data available  7  – 
Australia and Pacific Islands  Australia, Pacific Islands  No data available  6  – 
Africa  Africa, Cape Verde Islands, Congo  No data available  3  – 
Central America  Mexico  No data available  1  – 
      Total: 233
c   
aLesser Antilles: Antigua and Barbuda, Barbados, Dominica, Grenada, Guadeloupe, Martinique, St. Lucia, St. Vincent, and Grenadines.  
bGreater Antilles: Bahamas, Cayman Islands, Dominican Republic, Haiti, Jamaica, Cuba. 
cA total of 233 destinations were mentioned by 225 patients (6 mentioned 2 destinations, l mentioned 3); 5 patients did not provide information about predisease travel, 
and l case arose in Germany. rise in German case reports, particularly during late 2001
and the first half of 2002, corresponds to a surge of local
dengue reporting from many dengue–endemic areas and
likely reflects a true increase in imported cases. By num-
ber of reports of travel-associated infectious diseases,
dengue fever is second only to malaria (≈1,000 cases per
year, with a 15% drop in cases from 2001 to 2002) in
Germany. Aparallel voluntary sentinel surveillance system
for imported tropical infections in Germany recorded 78
dengue cases in 2001 and 125 cases in 2002, respectively
(5). For this system, sites include infectious disease and
tropical medicine centers, as well as offices of general
practitioners specialized in travel medicine. By definition,
there is much overlap of cases between the Robert Koch
Institute’s mandatory reporting surveillance system, and
the voluntary sentinel system. The fact that in 2001 more
cases were reported to the sentinel system compared to the
institute’s surveillance shows that reporting in the latter
system was incomplete in its first year. However, com-
pleteness of reporting was much improved in 2002.
The spectrum of countries of infection reflects both pre-
dominating travel destinations and local trends in dengue
fever endemicity, with risk for individual travelers high in
both popular tourist destinations, such as Thailand or
Brazil, as well as some regions visited by smaller numbers
of travelers, including some Caribbean islands. Within
countries endemic for the disease, dengue risk varies by
place, season, and year. Urban areas can have intense and
prolonged local epidemics. Introduction of a dengue virus
serotype for which the population lacks immunity can
cause particularly high incidence, and climate may have a
strong influence on vector populations. Such fluctuations
likely influenced German data. 
The increase in cases from the fourth quarter of 2001 to
the first quarter of 2002 is mainly due to cases imported
from Brazil. During the first quarter of 2002, the state of
Rio de Janeiro recorded an incidence that was 6.5 times
higher than it had been in January through March of 2001.
This state alone accounted for almost 50% of the total
cases in Brazil during this period (6), including an urban
epidemic in the city of Rio de Janeiro. Rio draws large
numbers of German tourists, especially during the festival
of Carnival, which most likely contributed to the high
number of cases acquired in Brazil in February and March
2002 (Figure 3). In contrast, the decrease in incidence in
neighboring Venezuela (from 338/100,000 in 2001 [7] to
153/100,000 in 2002 [8]) corresponded to a significant
decrease in the percentage of German travelers who
acquired the disease there.
The peak in cases imported to Germany in the second
and third quarter of 2002 reflects the dengue season in
Thailand and other parts of Southeast Asia. In Thailand,
the disease is associated with the rainy season, which
varies regionally but in most areas starts around April. In
mid-April of 2002, an out-of-season outbreak was report-
ed at the island resort of Koh Phangan (9), which may
explain the high incidence among German travelers in
March and April. Our data highlight the contribution of
Southeast Asia as an area where German travelers acquire
dengue fever. These findings agree with those from a
Swedish case-control study, which identified travel to the
Malay Peninsula as an independent risk factor for import-
ed dengue (10) and with reports from a European network
of institutions of tropical medicine (11). Although nosoco-
mial transmission of the virus in dengue-nonendemic areas
is rare, the case detected by our surveillance system clear-
ly shows the potential of bloodborne virus transmission
and the need to follow strict hygiene precautions when
treating dengue patients.
The new infectious disease surveillance system in
Germany, based on clinical case definitions and laboratory
confirmation, is one of the few national surveillance sys-
tems in industrialized countries to include dengue fever
with a specific case definition. As asymptomatic and mild
infections are known to occur, some proportion of infec-
tions will escape diagnosis (12,13). Dengue is an important
differential diagnosis of fever in travelers to endemic areas
(12,14). In a German study, travelers who had fever after
returning from dengue-endemic areas had dengue antibody
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Figure 2. Risk for dengue fever (DF) among travelers to Thailand,
2002. 
Figure 3. Risk for dengue fever (DF) among German travelers to
Brazil, 2002 (Tourism data from 2001). seroprevalence rates of 7% (15). As long distance travel
expands, increasing numbers of travelers are potentially
exposed to dengue viruses and more often exposed sequen-
tially to multiple serotypes of dengue virus, increasing
their potential risk for dengue hemorrhagic fever or dengue
shock syndrome. Additional serologic studies in represen-
tative samples of symptomatic and asymptomatic travelers
are needed to investigate the risk in defined areas.
In its second year, Germany’s dengue surveillance
demonstrated a rough parallel in the rate of returning trav-
elers with dengue fever and its incidence in the places they
had visited. One strength of this study was its analysis of
trends on the basis of incidence specific for country of des-
tination. Systematically collected and analyzed surveil-
lance data on imported infections help formulate
region-specific travel advice in addition to information on
avoiding the vectors of dengue fever. 
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